Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

(NASDAQ:CMND),(Frankfurt:CWY0), Prestigious Hadassah Medical Center Joins Yale, Johns Hopkins, Tel Aviv Sourasky and IMCA, in Evaluating the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate Vancouver, Canada, Nov. 20, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived […]

Exponential Science Launches ES Accelerator to Back Deep-Tech Founders Building the Future

Exponential Science (ES) announced today the launch of theES Accelerator, a founder-focused programme powered by venture builder H-FARM – ranked among the Financial Times' Top 10 European Startup Hubs – and designed to support ambitious early-stage companies leveraging exponential technologies, including distributed ledger technology (DLT), artificial intelligence, and quantum computing, to build an equitable and

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site GlobeNewswire November 20, 2025 Prestigious Hadassah Medical Center Joins Yale, Johns Hopkins, Tel Aviv Sourasky and IMCA, in Evaluating the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate Vancouver, Canada, Nov. 20, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq:

Crucial Innovations Corp. Signs Management Services Agreement with South African Licensed Medicinal Cannabis Cultivator Cannabudgrow (Pty) Ltd

(OtherOTC:CINV), LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) — Crucial Innovations Corp., a pioneering medical cannabis company, announced the signing of a Management Services Agreement (MSA) with Cannabudgrow (Pty) Ltd (“CBG”), a licensed cultivator and exporter of medicinal cannabis based in Johannesburg, South Africa. Under the terms of the agreement, Crucial Innovations will provide CBG with

4th Edition of bioMerieux Canada Symposium: Over 300 Canadian Health Experts Unite in Toronto to Tackle the Growing Threat of Antimicrobial Resistance

TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) — More than 300 clinicians, researchers, and decision makers from across Canada gathered in Toronto on November 18-19 for the fourth annual bioMerieux Canada Antimicrobial Resistance (AMR) Symposium. Under the theme “Preserving Antimicrobial Effectiveness: Acting Today for Future Generations,” the two-day event showcased the latest science, innovations, and public-health

Sonatype Intelligence Reveals CVE Program Leaves Majority of Vulnerabilities Unscored

Fulton, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) — Sonatype(R), the leader in AI-driven DevSecOps, today released a new report, “Trust Issues: The CVE Crisis,” revealing that the world's most widely used vulnerability index — the Common Vulnerabilities and Exposures (CVE) system — struggles to keep pace with the realities of modern software development. The study

Experts and Families Warn of Risks from AI Therapy Chatbots

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) — Nine in ten U.S. adults say the nation is facing a mental health crisis, and experts, parents and policymakers are increasingly concerned about the rise of generative-AI therapy chatbots. For Matthew and Maria Raine, the danger became devastatingly real this April when their son, Adam, took his

Osisko Intersects 138 Metres Averaging 1.45% Cu in South Extension at Gaspe

(TSX:OM),(Boerse Frankfurt – Freiverkehr:0B51),(OTC US:OMZNF),(Other OTC:OMZNF), MONTREAL, Nov. 20, 2025 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company or “Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce new drill results from the Gaspe Copper Project, located in the Gaspe Peninsula of Eastern Quebec. Osisko Metals CEO Robert Wares commented: “These latest

KBR and Axiom Space Successfully Test Next-Generation Spacesuit in Critical Step Toward Returning to the Moon

(NYSE:KBR), HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) and Axiom Space successfully completed the first uncrewed thermal vacuum test of the Axiom Extravehicular Mobility Unit (AxEMU) Pressure Garment, which is designed to support astronauts during the Artemis III mission – the first crewed lunar landing in more than 50 years. The test

Scroll to Top